Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma. Jun 2010 - Am. J. Respir. Crit. Care Med.; 181(12):1535-4970 [PMID:20167848] [Hegmans JP] [Veltman JD] [Lambers ME] [de Vries IJ] [Figdor CG] [Hendriks RW] [Hoogsteden HC] [Lambrecht BN] [Aerts JG]
Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses. Jun 2006 - Eur. Respir. J.; 27(6):0903-1936 [PMID:16540497] [Hegmans JP] [Hemmes A] [Hammad H] [Boon L] [Hoogsteden HC] [Lambrecht BN]
Immunotherapy of murine malignant mesothelioma using tumor lysate-pulsed dendritic cells. Mai 2005 - Am. J. Respir. Crit. Care Med.; 171(10):1073-449X [PMID:15764728] [Hegmans JP] [Hemmes A] [Aerts JG] [Hoogsteden HC] [Lambrecht BN]
